Furthermore, we could demonstrate that activated NF-κB was restricted to cells in the close vicinity of early plaques in AD patient brains (Kaltschmidt et al., 1997; Ferrer et al., 1998). This evidence concerns the gene NFKB1 and Alzheimer disease.